封面
市場調查報告書
商品編碼
2177759

脂質體營養遞送組成市場預測至2034年-按組分類型、組成形態、應用、商業化通路、最終用戶、生產規模和地區分類的全球分析

Liposomal Nutrient Delivery Ingredients Market Forecasts to 2034 - Global Analysis By Ingredient Types, Ingredient Forms, Applications, Commercialization Channels, End Users, Production Scales, and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 300+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測,全球脂質體營養輸送市場預計到 2026 年將達到 7 億美元,並在預測期內以 14.0% 的複合年成長率成長,到 2034 年達到 20 億美元。

脂質體營養遞送成分是包裹在磷脂雙層囊泡內的生物活性化合物,可在加工和消化過程中保護和運輸營養物質。這些成分包括含有維生素、礦物質、多酚、ω-3脂肪酸和類胡蘿蔔素的脂質體,可提高生物利用度、掩蓋不良味道並增強在水性系統中的分散性。這些成分以粉末、濃縮液、糊狀物、顆粒和冷凍形式供應,用於保護益生菌活性、延長保存期限、促進胃腸道遞送、耐熱、強化粉末混合物的營養以及配製機能飲料。

對提高生物利用度的需求

消費者對高效吸收營養的需求日益成長,推動了脂質體遞送技術的應用。脂質體能夠保護活性成分在整個消化過程中免受破壞,並提高全身吸收率。維生素、多酚和ω-3脂肪酸等營養物質以傳統形式存在時生物利用度通常較低,而脂質體包裹技術則能有效解決這一難題。各大品牌正著重強調其高階膳食補充品和機能飲料中吸收率提升的優勢。消費者意識的這種轉變,正在推動已開發市場整體膳食補充劑和飲料產品的定價和銷售成長。

成本和穩定性限制

由於磷脂原料、包封製程和品管成本高昂,脂質體基成分與傳統營養形式相比仍然價格昂貴。脂質體對pH值、溫度和剪切力敏感,這使得它們難以添加到加工食品和飲料中。儲存過程中的物理穩定性問題會導致洩漏和功效降低。這些成本和穩定性方面的障礙限制了脂質體基成分的早期應用,目前主要集中在高階膳食補充劑和高價值機能飲料領域,而非主流食品類別。

機能飲料配方

機能飲料配方的開發為脂質體成分生產商提供了巨大的機遇,使其能夠提供即使在水性、酸性和熱處理環境下也能保持穩定性和適口性的營養成分。脂質體能夠保護敏感的活性成分,同時掩蓋苦味和金屬味。與飲料品牌建立合作開發夥伴關係,為展示產品功效和實現大規模生產提供了機會。隨著消費者對便利營養攝取的需求日益成長,脂質體成分有望在機能飲料和膳食補充劑管道中獲得高價位和長期供應合約。

以常規營養形式替代

傳統維生素、礦物質和ω-3成分價格低廉、性質穩定,且為食品和膳食補充劑生產商所熟知,因此他們不太願意為脂質體替代品支付更高的價格。許多配方研發人員認為,如果不需要生物利用度聲明,傳統形式就足夠了。如果封裝成本下降緩慢,或者監管機構對吸收聲明的審查力度加大,那麼脂質體替代品的應用可能仍將局限於高階品牌。因此,生產商必須證明其具有可衡量的生物利用度優勢。

新型冠狀病毒(COVID-19)的影響

疫情期間,消費者對免疫力和整體健康的關注度顯著提升,在醫療資源有限的情況下,推動了對高階營養補充品和強化飲料的需求。危機期間,脂質體維生素產品的電商銷售量激增,促進了其普及。疫情後,人們對有效營養輸送的持續關注推動了市場需求,同時生產商也不斷改進穩定技術,以提升加工食品配方的營養價值。

在預測期內,「維生素包裹脂質體」細分市場預計將佔據最大的市場佔有率。

由於消費者對維生素的高度認知、其在高階膳食補充劑中的成熟應用以及顯著的生物利用度優勢,預計在預測期內,維生素脂質體包裹產品將佔據最大的市場佔有率。在初期商業銷售方面,維生素C和B群維生素脂質體產品佔據主導地位。隨著各大品牌不斷拓展其脂質體產品線,含維生素配方仍是該領域的入門級產品和銷售支柱,從而在整個脂質體營養遞送領域保持著領先的銷售佔有率。

預計在預測期內,「粉末」細分市場將呈現最高的複合年成長率。

在預測期內,粉狀產品預計將呈現最高的成長率,這主要得益於生產商對易於走私、膠囊和粉狀飲料混合原料的偏好,這些原料易於添加、保存期限長且易於混合。與液體脂質體懸浮液相比,粉末狀產品重量更輕,保存期限更長。隨著乾燥和穩定技術的進步,用於膳食補充劑和機能性食品的粉狀產品市場蓬勃發展,使其成為成長最快的原料劑型細分市場。

市佔率最大的地區

在預測期內,北美預計將佔據最大的市場佔有率,這得益於其成熟的膳食補充劑市場、消費者對脂質體產品的高度認知以及對遞送技術的集中投資。美國是推動區域銷售的主要力量,這主要歸功於銷售脂質體維生素和礦物質的品牌。對膳食補充劑新創企業的積極創業融資進一步鞏固了該地區在脂質體營養遞送成分領域的領先地位。

複合年成長率最高的地區

在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於膳食補充劑消費量的成長、人們對生物利用度的日益關注,以及中國、日本、印度和韓國生產能力的提升。當地生產商正在擴大脂質體產能,而各品牌則透過遞送技術實現差異化競爭。這些需求促進因素使亞太地區成為成長最快的區域市場。

目標區域

北美洲

我們

加拿大

墨西哥

歐洲

英國

德國

法國

義大利

西班牙

荷蘭

比利時

瑞典

瑞士

波蘭

其他歐洲國家

亞太地區

中國

日本

印度

韓國

澳洲

印尼

泰國

馬來西亞

新加坡

越南

其他亞太國家

南美洲

巴西

阿根廷

哥倫比亞

智利

秘魯

其他南美國家

世界其他地區(RoW)

中東

沙烏地阿拉伯

阿拉伯聯合大公國

卡達

以色列

其他中東國家

非洲

南非

埃及

摩洛哥

其他非洲國家

免費客製化服務

所有購買此報告的客戶均可選擇以下免費自訂選項之一。

  • 企業概況
    • 對其他市場參與企業(最多 3 家公司)進行全面分析
    • 對主要公司進行SWOT分析(最多3家公司)
  • 區域細分
    • 根據客戶要求,我們可以提供主要國家的市場估算和預測,以及複合年成長率(註:需進行可行性檢查)。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章:研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章:競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章:全球脂質體營養遞送成分市場:依成分類型分類

  • 維生素包裹的脂質體
  • 含礦物質的脂質體
  • 含多酚的脂質體
  • ω-3 包裹脂質體
  • 類胡蘿蔔素包裹的脂質體

第6章:全球脂質體營養遞送成分市場:以成分形式分類

  • 粉末
  • 濃縮液
  • 貼上
  • 顆粒
  • 冷凍原料

第7章 全球脂質體營養遞送組成市場:依應用分類

  • 維持益生菌的存活率
  • 穩定保存期限
  • 胃腸道輸送
  • 熱處理保護
  • 粉末混合物的營養強化
  • 機能飲料的配方

第8章 全球脂質體營養遞送組成市場:依商業化管道分類

  • 廠商直銷
  • 原物料經銷商
  • B2B市場
  • 契約製造夥伴關係

第9章 全球脂質體營養遞送組成市場:依最終用戶分類

  • 食品和飲料製造商
  • 原料混合公司
  • 代工食品製造商
  • 餐廳經營者
  • 營養補充品製造商
  • 研究與發展機構

第10章 脂質體營養遞送組成的全球市場:依生產規模分類

  • 實驗室規模
  • 中試規模
  • 商業規模

第11章 全球脂質體營養遞送組成市場:按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區(RoW)
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章:公司簡介

  • BASF SE
  • Croda International Plc
  • Evonik Industries AG
  • Symrise AG
  • Givaudan SA
  • DSM-Firmenich AG
  • Ashland Inc
  • Clariant AG
  • Kerry Group plc
  • International Flavors & Fragrances Inc
  • Lonza Group AG
  • Solvay SA
  • Lubrizol Corporation
  • Seppic SA
  • Lucas Meyer Cosmetics
  • and Nouryon Holding BV
Product Code: SMRC41565

According to Stratistics MRC, the Global Liposomal Nutrient Delivery Ingredients Market is accounted for $0.7 billion in 2026 and is expected to reach $2.0 billion by 2034 growing at a CAGR of 14.0% during the forecast period. Liposomal nutrient delivery ingredients are bioactive compounds enclosed within phospholipid bilayer vesicles that protect and transport nutrients through processing and digestion. They include vitamin-loaded, mineral-loaded, polyphenol-loaded, omega-3, and carotenoid-loaded liposomes that improve bioavailability, mask taste, and enable dispersion in aqueous systems. These ingredients are supplied as powders, liquid concentrates, pastes, granules, and frozen forms and are used in probiotic viability protection, shelf-life stabilization, gastrointestinal delivery, heat process protection, powder blend fortification, and functional beverage formulation.

Market Dynamics:

Driver:

Bioavailability Enhancement Demand

Growing demand for nutrients that absorb effectively is driving adoption of liposomal delivery ingredients that protect actives through digestion and improve systemic uptake. Vitamins, polyphenols, and omega-3 fatty acids often suffer poor bioavailability in conventional formats, and liposomal encapsulation addresses this limitation. Brands highlight absorption claims in premium supplements and functional beverages. This behavioral shift supports premium pricing and volume growth across supplement and beverage applications in developed markets.

Restraint:

Cost and Stability Constraints

Liposomal ingredients remain expensive relative to conventional nutrient forms, because phospholipid raw materials, encapsulation processing, and quality control add substantial cost. Liposomes are sensitive to pH, temperature, and shear, which complicates incorporation into processed foods and beverages. Physical stability during storage can lead to leakage and reduced efficacy. These cost and stability barriers confine early adoption to premium supplements and high-value functional beverages rather than mainstream food categories.

Opportunity:

Functional Beverage Formulation

Functional beverage formulation creates substantial opportunity for liposomal ingredient producers to supply nutrients that remain stable and palatable in aqueous, acidic, and thermally processed systems. Liposomes mask bitter and metallic notes while protecting sensitive actives. Co-development partnerships with beverage brands provide validation and volume. As consumers seek convenient nutrient delivery, liposomal ingredients can capture premium pricing and long-term supply agreements across functional beverage and supplement channels.

Threat:

Substitution by Conventional Nutrient Forms

Conventional vitamin, mineral, and omega-3 ingredients remain inexpensive, stable, and familiar to food and supplement manufacturers, which reduces willingness to pay premiums for liposomal alternatives. Many formulators perceive conventional forms as sufficient when bioavailability claims are not required. If encapsulation costs decline slowly or regulatory scrutiny of absorption claims increases, adoption may remain confined to premium brands. Consequently, producers must demonstrate measurable bioavailability advantages.

Covid-19 Impact:

The pandemic heightened consumer interest in immune and overall health, driving demand for premium supplements and fortified beverages during a period of restricted healthcare access. During the crisis, e-commerce purchases of liposomal vitamin products expanded, supporting adoption. Post-pandemic, sustained interest in effective nutrient delivery has reinforced demand, while producers advanced stability technologies to improve incorporation into processed foods.

The Vitamin-Loaded Liposomes segment is expected to be the largest during the forecast period

The Vitamin-Loaded Liposomes segment is expected to account for the largest market share during the forecast period, due to strong consumer recognition of vitamins, established use in premium supplements, and clear bioavailability positioning. Vitamin C and B-complex liposomal products dominate early commercial volumes. As brands expand liposomal portfolios, vitamin-loaded formulations remain the entry point and volume anchor, thereby sustaining leading revenue share across the liposomal nutrient delivery ingredients category.

The Powders segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Powders segment is predicted to witness the highest growth rate, driven by formulator preference for shelf-stable, easily blended ingredients that integrate into sachets, capsules, and dry beverage mixes. Powders reduce transport weight and support long shelf life compared with liquid liposomal suspensions. As drying and stabilization technology improves, powder launches multiply across supplement and functional food applications, making this the fastest-growing ingredient form segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to a mature supplement market, strong consumer familiarity with liposomal products, and concentrated investment in delivery technology. The United States dominates regional revenue, supported by brands marketing liposomal vitamins and minerals. Active venture funding for supplement startups further reinforces the region's leading position in liposomal nutrient delivery ingredients.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding supplement consumption, rising interest in bioavailability, and growing manufacturing capability across China, Japan, India, and South Korea. Local producers are scaling liposomal capacity, while brands seek differentiation through delivery technology. These demand catalysts make Asia Pacific the fastest-growing regional market.

Key players in the market

Some of the key players in Liposomal Nutrient Delivery Ingredients Market include BASF SE, Croda International Plc, Evonik Industries AG, Symrise AG, Givaudan SA, DSM-Firmenich AG, Ashland Inc., Clariant AG, Kerry Group plc, International Flavors & Fragrances Inc., Lonza Group AG, Solvay SA, Lubrizol Corporation, Seppic S.A., Lucas Meyer Cosmetics, and Nouryon Holding B.V.

Key Developments:

In October 2026, DSM-Firmenich AG launched a vitamin-loaded liposomal powder for supplement sachets and beverage mixes, supported by bioavailability testing and distributed through direct manufacturer sales and business-to-business marketplaces across European and North American markets.

In September 2026, Kerry Group plc expanded its liposomal portfolio with polyphenol- and omega-3-loaded liposomes positioned for functional beverage formulation, targeting beverage manufacturers through ingredient distributors and contract manufacturing partnerships.

In August 2026, Evonik Industries AG introduced carotenoid-loaded liposomes in liquid concentrate and granule formats for powder blend fortification and shelf-life stabilization, distributed through direct sales and technology licensing partnerships across Asia Pacific food processing channels.

Ingredient Types Covered:

  • Vitamin-Loaded Liposomes
  • Mineral-Loaded Liposomes
  • Polyphenol-Loaded Liposomes
  • Omega-3 Liposomes
  • Carotenoid-Loaded Liposomes

Ingredient Forms Covered:

  • Powders
  • Liquid Concentrates
  • Pastes
  • Granules
  • Frozen Ingredients

Applications Covered:

  • Probiotic Viability Protection
  • Shelf-Life Stabilization
  • Gastrointestinal Delivery
  • Heat Process Protection
  • Powder Blend Fortification
  • Functional Beverage Formulation

Commercialization Channels Covered:

  • Direct Manufacturer Sales
  • Ingredient Distributors
  • Business-to-Business Marketplaces
  • Contract Manufacturing Partnerships

End Users Covered:

  • Food and Beverage Manufacturers
  • Ingredient Blenders
  • Contract Food Manufacturers
  • Foodservice Operators
  • Nutraceutical Manufacturers
  • Research and Development Laboratories

Production Scales Covered:

  • Laboratory Scale
  • Pilot Scale
  • Commercial Scale

Regions Covered:

North America

United States

Canada

Mexico

Europe

United Kingdom

Germany

France

Italy

Spain

Netherlands

Belgium

Sweden

Switzerland

Poland

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Thailand

Malaysia

Singapore

Vietnam

Rest of Asia Pacific

South America

Brazil

Argentina

Colombia

Chile

Peru

Rest of South America

Rest of the World (RoW)

Middle East

Saudi Arabia

United Arab Emirates

Qatar

Israel

Rest of Middle East

Africa

South Africa

Egypt

Morocco

Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling

Comprehensive profiling of additional market players (up to 3)

SWOT Analysis of key players (up to 3)

Regional Segmentation

Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)

Competitive Benchmarking

    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Liposomal Nutrient Delivery Ingredients Market, By Ingredient Types

  • 5.1 Vitamin-Loaded Liposomes
  • 5.2 Mineral-Loaded Liposomes
  • 5.3 Polyphenol-Loaded Liposomes
  • 5.4 Omega-3 Liposomes
  • 5.5 Carotenoid-Loaded Liposomes

6 Global Liposomal Nutrient Delivery Ingredients Market, By Ingredient Forms

  • 6.1 Powders
  • 6.2 Liquid Concentrates
  • 6.3 Pastes
  • 6.4 Granules
  • 6.5 Frozen Ingredients

7 Global Liposomal Nutrient Delivery Ingredients Market, By Applications

  • 7.1 Probiotic Viability Protection
  • 7.2 Shelf-Life Stabilization
  • 7.3 Gastrointestinal Delivery
  • 7.4 Heat Process Protection
  • 7.5 Powder Blend Fortification
  • 7.6 Functional Beverage Formulation

8 Global Liposomal Nutrient Delivery Ingredients Market, By Commercialization Channels

  • 8.1 Direct Manufacturer Sales
  • 8.2 Ingredient Distributors
  • 8.3 Business-to-Business Marketplaces
  • 8.4 Contract Manufacturing Partnerships

9 Global Liposomal Nutrient Delivery Ingredients Market, By End Users

  • 9.1 Food and Beverage Manufacturers
  • 9.2 Ingredient Blenders
  • 9.3 Contract Food Manufacturers
  • 9.4 Foodservice Operators
  • 9.5 Nutraceutical Manufacturers
  • 9.6 Research and Development Laboratories

10 Global Liposomal Nutrient Delivery Ingredients Market, By Production Scales

  • 10.1 Laboratory Scale
  • 10.2 Pilot Scale
  • 10.3 Commercial Scale

11 Global Liposomal Nutrient Delivery Ingredients Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiling

  • 14.1 BASF SE
  • 14.2 Croda International Plc
  • 14.3 Evonik Industries AG
  • 14.4 Symrise AG
  • 14.5 Givaudan SA
  • 14.6 DSM-Firmenich AG
  • 14.7 Ashland Inc
  • 14.8 Clariant AG
  • 14.9 Kerry Group plc
  • 14.10 International Flavors & Fragrances Inc
  • 14.11 Lonza Group AG
  • 14.12 Solvay SA
  • 14.13 Lubrizol Corporation
  • 14.14 Seppic S.A
  • 14.15 Lucas Meyer Cosmetics
  • 14.16 and Nouryon Holding B.V

List of Tables

  • Table 1 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Ingredient Types (2023-2034) ($MN)
  • Table 3 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Vitamin-Loaded Liposomes (2023-2034) ($MN)
  • Table 4 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Mineral-Loaded Liposomes (2023-2034) ($MN)
  • Table 5 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Polyphenol-Loaded Liposomes (2023-2034) ($MN)
  • Table 6 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Omega-3 Liposomes (2023-2034) ($MN)
  • Table 7 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Carotenoid-Loaded Liposomes (2023-2034) ($MN)
  • Table 8 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Ingredient Forms (2023-2034) ($MN)
  • Table 9 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Powders (2023-2034) ($MN)
  • Table 10 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Liquid Concentrates (2023-2034) ($MN)
  • Table 11 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Pastes (2023-2034) ($MN)
  • Table 12 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Granules (2023-2034) ($MN)
  • Table 13 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Frozen Ingredients (2023-2034) ($MN)
  • Table 14 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Applications (2023-2034) ($MN)
  • Table 15 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Probiotic Viability Protection (2023-2034) ($MN)
  • Table 16 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Shelf-Life Stabilization (2023-2034) ($MN)
  • Table 17 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Gastrointestinal Delivery (2023-2034) ($MN)
  • Table 18 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Heat Process Protection (2023-2034) ($MN)
  • Table 19 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Powder Blend Fortification (2023-2034) ($MN)
  • Table 20 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Functional Beverage Formulation (2023-2034) ($MN)
  • Table 21 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Commercialization Channels (2023-2034) ($MN)
  • Table 22 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Direct Manufacturer Sales (2023-2034) ($MN)
  • Table 23 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Ingredient Distributors (2023-2034) ($MN)
  • Table 24 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Business-to-Business Marketplaces (2023-2034) ($MN)
  • Table 25 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Contract Manufacturing Partnerships (2023-2034) ($MN)
  • Table 26 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By End Users (2023-2034) ($MN)
  • Table 27 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Food and Beverage Manufacturers (2023-2034) ($MN)
  • Table 28 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Ingredient Blenders (2023-2034) ($MN)
  • Table 29 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Contract Food Manufacturers (2023-2034) ($MN)
  • Table 30 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Foodservice Operators (2023-2034) ($MN)
  • Table 31 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Nutraceutical Manufacturers (2023-2034) ($MN)
  • Table 32 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Research and Development Laboratories (2023-2034) ($MN)
  • Table 33 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Production Scales (2023-2034) ($MN)
  • Table 34 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Laboratory Scale (2023-2034) ($MN)
  • Table 35 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Pilot Scale (2023-2034) ($MN)
  • Table 36 Global Liposomal Nutrient Delivery Ingredients Market Outlook, By Commercial Scale (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.